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ABSTRACT 
 
Wound healing is a physiological event that leads to the restoration of normal structure 
and in damaged tissues. Several natural products, such as lectins, have been shown to 
accelerate the healing process. Thus, in the present study, the Synadenium carinatum latex 
lectin (ScLL) was isolated and investigated for its healing properties that optimizes the 
restoration process of the injured tissue. Dorsal skin wounds were created in mice, which 
were divided in groups treated with ScLL at concentrations of 250 and 500 μg/ml and 
group treated with water (control). ImageJ program was used to measure the contraction 
of wounds and tissue sections were stained with Haematoxilin and Eosin for histological 
assay using Picro-Sirius Red for collagen determination content. Concerning about the 
results, ScLL lectin, in the macroscopic evaluation demonstrated better performance in 
the wound contraction, when compared to control. In the histological analysis, the ScLL 
presented an intense re-epithelialization level occurring faster than control group. In 
addition, we showed that ScLL 500 µg/ml presented a lower concentration of collagen 
than control group, however possesses anti-keloids properties by its ability to reduce 
exacerbated deposition of collagen. 
 
 
 
 
 
Keywords: Synadenium carinatum, lectin, wound healing 
  
  
 
SUMMARY 
 
 
1. INTRODUCTION......................................................................................................... 2 
2. MATERIAL AND METHODS ................................................................................... 2 
  2.1Plant material............................................................................................................. 3 
  2.2 Animals .................................................................................................................... 3 
  2.3 Purification and determination of the hemagglutinating activity of ScLL.………...3  
  2.4 Hemolytic assay ....................................................................................................... 3  
  2.5 Cytotoxicity assay .................................................................................................... 4 
  2.6 Evaluation of healing effect.......................................................................................4 
  2.7 Histopathological analysis……….......……………………………..………………5 
  2.8 Statistical analysis…………………………….......………………………………...5 
3. RESULTS………...………………………………………………………….………..6 
  3.1 Characterization of ScLL lectin……………………………………………………..6 
  3.2. Evaluation of healing effect………………………………………………………...6 
  3.3. Histological analysis………………………………...……………………………..7 
    3.3.1 Re-epithelization…………………………………………………………….…..8 
    3.3.2 Granulation Tissue…………………...…………………………………….……8 
    3.3.3. Inflammatory Infiltrate……………………………………………………….…9 
    3.3.4 Types of Inflammatory Cells……………………………………………………9 
    3.3.5 Vascular Proliferation…………………………………………………………...9 
  3.4 Histopathological analysis of the presence of lesions……………………………....9 
  3.5 Quantification of collagen………………………………………………………....10 
4. DISCUSSION………………………………………………………………………..10 
5. CONCLUSION……………………………………………………………...……….14 
REFERENCES…………………………………………………………………………15 
 
 
 
 
 
 
 
  
 
Wound healing effect of ScLL lectin from Synadenium carinatum latex in murine model 
 
 
 
 
 
Henrique Lara Peixoto Marquesa; Leandro William Borgesb; Julio Cesar Neves de 
Almeidaa; Francisco Cláudio Dantas Motab;  Tiago Wilson Patriarca Mineoa; Paulo 
Rogério de Fariac; Fernanda Maria Santiagoa* 
 
 
 
 
 
aLaboratory of Immunoparasitology “Dr. Mario Endsfeldz Camargo”, Institute of 
Biomedical Sciences, Federal University of Uberlândia, Av. Pará 1720, 38400-902 
Uberlândia, MG, Brazil; 
bFaculty of Veterinary Medicine, Federal University of Uberlândia, MG, Brazil; 
cDepartment of Morphology, Institute of Biomedical Science, Federal University of 
Uberlândia, MG, Brazil; 
 
 
 
 
 
 
 
Correspondence to:  
 
Laboratório de Imunoparasitologia – ICBIM - UFU  
Campus Umuarama – Bloco 4C – Uberlândia – MG – Brazil  
Phone: +55-(34)-3225-8666 – Fax: +55-(34)-3225 -8672  
*fmsantiago@ufu.br 
 
  
 
1 INTRODUCTION 
The wound healing process is a physiological process involving a variety of cells, 
cytokines, growth factors aiming to restore the structure and function of damaged tissues 
(CORIOLANO et al., 2014; PATEL et al., 2019). The repair process starts immediately 
after injury and includes the phases such as inflammation (neutrophils, macrophages and 
lymphocytes recruitment), proliferation (characterised by formation of granulation tissue) 
and maturation (extracellular matrix remodelling) (PANG et al., 2017; 
CHUNCHARUNEE et al., 2019). Moreover, all the stages are interdependent, 
overlapping and the healing is just complete when the disrupted surfaces are firmly knit 
by collagen (BUFFONI et al., 1993; MARTINS et al., 2006). However, many factors can 
affect one or more phases at wound healing such as age, obesity, stress, immunity status, 
patient’s behaviour in face of a damaged tissue and microbial infections (GUO; 
DIPIETRO, 2010). Therefore, the pharmaceutical has increasingly been appealing to 
discovery of new sources-derived drugs that are able to modulate in a positive way the 
wound healing process (GHOSH; GABA, 2013; TCHOUYA et al., 2015). 
Lectins are proteins, or glycoproteins of non-immune origin, that reversibly 
interact with carbohydrates and can be found in different organisms such as plants, 
animals, microorganisms, and virus. Some lectins participle in cell-cell communication, 
cancer metastasis, embryogenesis and tissue development (KARPOVA, 2016; HE et al., 
2017). Their ability to interact with glycan's moieties present on the surface of immune 
cells resulting in immunomodulatory effects has been widely showed in previous studies. 
Some plant lectins, as Con A from Canavalia ensiformis; PHA-E and PHA-L from 
Phaseolus vulgaris, ScLL from Synadenium carinatum are able to of induce Th1 
immunity with   high levels of IL-12 and IFN-γ production, while a few can stimulate 
Th2 immunity, inducing immune responses that could be beneﬁcial against diﬀ erent 
pathogens and tumors (SOUZA et al., 2013; SANDER; CORIGLIANO; CLEMENTE, 
2019).  
Plant lectins may also improve the wound healing process in skin through the 
induction of epithelial reconstruction and increased keratin deposition, as demonstrated 
by Neto et al. (2011) with Bauhinia variegata seeds lectin. Thus, the present study aim 
was to investigeate the healing potencial of the topical administration of  S. carinatum 
lectin on surgically induced wounds in a murine model. 
  
 
2 MATERIAL AND METHODS  
 
2.1 Plant material  
Synadenium carinatum latex was collected of plants, which were grown under 
natural conditions in the University Campus localized in Uberlândia, Minas Gerais, Brazil 
(940 m altitude, 18o53’05.56” S and 48o15’36.54” W), from September to December of 
the years 2017 and 2018. A voucher specimen (HUFU 38354) was identified and 
deposited at the Herbarium of the Federal University of Uberlândia (UFU). 
Crude extracts from S. carinatum were obtained from small incisions in the distal 
branches of plants and by mixing 15 mL aliquots with water at a ratio of 1:10. These 
extracts were then incubated 4°C for 24h and stored −80°C for 2 months. Afterwards, a 
rubber-like material was removed and the suspension was centrifuged at 12,000 g for 20 
min at 4°C. 
 
2.2 Animals  
Six to eight -week-old Female Balb/c mices weighing 25-30g were kept in the 
Animal Facility Center (CBEA) of Federal University of Uberlândia, MG, Brazil in 
standard animal cages (21Hx32Lx20W cm) under conventional laboratory conditions 
(12-h light/dark cycle, dark cycle starts at 19.00 h and 25°C), and supplied with water and 
food ad libitum. All procedures were conducted according to guidelines for animal ethics 
and this study had been approved by the Ethics Committee for Animal Experimentation 
of the UFU (protocol number 135/12). 
 
2.3 Purification and determination of the hemagglutinating activity of ScLL  
D-galactose-binding lectin (ScLL) was purified on immobilized D-galactose 
agarose column (Pierce, Rockford, Illinois, USA), balanced with 0.05 M borate-buffered 
saline (BBS), pH 7.2. The ScLL was eluded with 0.4 M D-galactose in BBS (BBS-D-gal) 
and dialyzed against Tris buffer (pH 7.2). The protein concentration was determined 
(BRADFORD, 1976) using bovine serum albumin as standard protocol. The 
electrophoretic profile of this lectin was visualized by SDS-PAGE (12%) (LAEMMLI, 
1970). Hemagglutination assays were performed to confirm ScLL lectin activity, as 
previously described (SOUZA et al., 2005). ScLL aliquots were stored at −20°C until 
using in vitro and in vivo assays. 
 
  
 
2.4 Hemolytic assay 
Balb/c mice erythrocytes were used to evaluate the hemolytic activity of ScLL 
lectin according to Silva et al. (2015) with some modifications. First the red blood cells 
were collected and washed twice with 0.9% NaCl (w/v). Next 0.5% erythrocytes (v/v) 
were incubated at 37 ºC in the presence of ScLL in the concentrations ranging from 0.39 
to 200 µg/mL for 1 hour. After that, the samples were centrifuged (450g for 5 min) and 
cell lysis determined by spectroscopically as absorbance at 540 nm. The absorbance 
measured from lysed red blood cells in presence of 1% (v/v) Triton X-100 was considered 
as 100%. All results were obtained from three independent experiments made each one 
in triplicate. 
 
2.5 Cytotoxicity assay  
In order to determine ScLL cytotoxic activity, we performed the MTT assay by 
using Human Foreskin Fibroblasts (HFF) (ATCC SCRC-1041.1) and peritoneal murine 
macrophages, as previously described by Mosmann (1983) with some modification. The 
cells were cultured separately in 96-well plates (1 x 105 cells/well) in triplicate and treated 
with ScLL lectin in different concentrations (0.39 to 200 μg/mL) for 18h at 37oC and 5% 
CO2. As control the HFF and macrophages were treated with only complete RPMI 
medium. This experiment was performed in triplicate wells and all results obtained of 
three independently observations. 
 
2.6 Evaluation of healing effect  
The evaluation of the healing effect was based on macroscopic and microscopic 
criteria, of a circular excision wound model. 
Female of Balb/c mice (n=45) were randomly allocated into 9 groups (n=5) and 
submitted to one dorsal skin wound each. Briefly, the animals were anesthetized with 
xylazine (15 mg/Kg IM/intramuscular) and ketamine (100 mg/Kg, IM/intramuscular). 
After the hair was removed from the back of each mice, the surgical procedure was carried 
out in the skin area marked by a 7.5 mm-metal "punch", and the fragment was taken out 
preserving muscle fascia underneath. After one hour of the surgery, the lesions’ mice 
belonging to Groups 1, 2 and 3 were treated with ScLL in the concentrations of 250 μg/ml 
by 5, 10 and 15 days respectively; Groups 4, 5 and 6 were treated ScLL in the 
concentration of 500 μg/ml by 5, 10 and 15 days respectively and Groups 7, 8 and 9 the 
lesions were treated with only vehicle (water) by 5, 10 and 15 days respectively. The local 
  
 
treatment of the lesions and the measurement (photos) were conducted once a day, at the 
same time. During the course of the treatment, the scars were photographed using an high 
digital camera (Sony Cyber-shot) and the wound areas calculated by ImageJ program. 
The percentage wound contraction was calculated using the following equation: 
 
 
 
2.7 Histopathological analysis 
 For histological analysis purpose, mice were euthanized at day 5, 10, and 15 post-
treatment with Thiopental (150mg/kg) injected intraperitoneally followed by cervical 
dislocation. After euthanize, the tissue samples were fixated in 10% formalin buffer for 
24h, embedded in paraffin and tissue sections stained with hematoxylin-eosin (HE), full 
evaluation of tissue sections, and Picro-Sirus Red was used to quantify collagen fibers 
deposition by using ImageJ software. 
The HE findings were analyzed according with the following criteria: 
Re-epithelialization - classified as absent when there was no visible epithelium in 
the optical field; discreet or moderate, when it appeared incomplete or partial; and intense 
when fully or completely visualized on the connective tissue. 
Granulation Tissue - classified as absent when there was no visible tissue; discreet 
when it appeared only on the border, moderate when it appeared incomplete; and intense 
when present on the entire extent of the wound. 
Intensity of Inflammatory Infiltrate - classified as absent when there was no visible 
inflammatory infiltrate; discreet when cells appeared isolated; moderate when not 
involved the entire extent of the wound; and intense when present on the entire extent of 
the wound. 
Types of Inflammatory Cells - classified as absent when there was no visible 
inflammatory cells; discreet when had predominance of polymorphonuclear cells; 
moderate when there were polymorphonuclear and mononuclear cells; and intense when 
there were predominance of mononuclear cells. 
Vascular Proliferation - classified as absent when there was no visible vascular 
proliferation; discreet when there were few vases on the edge; moderate when not 
involved the entire extent of the wound; and intense when present on the entire extent of 
the wound. 
 
wound area on day 0 – wound area on day n 
wound area on day 0 
x 100 % of contraction = 
  
 
2.8 Statistical analysis 
 Statistical analysis was carried out using GraphPad Prism v.5.0 (GraphPad Software, 
Inc., La Jolla, CA). To compare all groups (control; ScLL in the concentrations of 250 
and 500 μg/ml) in relation to treatment days (5, 10 and 15), two-way ANOVA test was 
used followed by Bonferroni post-test. To analyze the cell viability and cell hemolysis 
data were used nonparametric Kruskal Wallis test, followed by Dunn’s test. All data are 
expressed as mean ± S.D. Statistical values p˂0.05 were considered significant. 
 
3 RESULTS 
 
3.1 Characterization of ScLL lectin  
Electrophoretic by SDS-PAGE profile of S. carinatum crude extract showed several 
peptide components, with relative molecular masses (Ms) ranging from 28 to 98 kDa 
(Figure 1B). These proteins after purification on galactose affinity chromatography 
demonstrated galactose non-binding proteins (void) corresponded to fractions 2-10 and 
resin binding proteins (lectin) were eluted with 400 mM of galactose between fractions 
20–22 (Figure 1A). The electrophoretic profile of the lectin demonstrated a protein with 
two subunits and apparent molecular weights of 28 and 30 kDa (Figure 1B).  Moreover, 
this lectin was incubated with 2% murine erythrocytes and showed hemagglutinating 
activity (25.0 - 1.55 g) (Figure 1C), 7 thus confirming lectinic activity and identified as 
ScLL, a lectin previously isolated by Souza et al. (2005).  
The effects of ScLL lectin on the hemolysis of Balb/c mice erythrocytes and on 
cytotoxity of cells lines such as fibroblasts and peritoneal murine macrophages were 
assessed at different concentrations. After incubating 1 and 18 hours respectively, the 
ScLL lectin did not change the viability of these cells (Figure 1D and E).  
 
3.2. Evaluation of healing effect 
The macroscopic analyses were used to determine to wound healing activity of 
the ScLL lectin in 15 days of the treatment. Photographs of the wounds of a representative 
mouse from each group were taken on day  1, 5, 8, 10, 13, and 15, respectively, after 
wound induction, at the end of the inflammatory phase, during formation of granulation 
tissue, during re-epithelialisation phase and including the day of sacrifice . 
The wounds of the mice of all groups on the first day showed bright red colour 
corresponding to the blood that covers the wound. At day 5, wound aspects differ across 
  
 
the treated groups with ScLL and vehicle used. In the control group, wounds showed a 
dark red colour while those from 250 and 500 µg/ml ScLL treated groups exhibited a 
brown color due to fibrin deposition on the surface of the scars. In the eighth day,  the 
mice treated with 500 µg/ml ScLL lectin demonstrated an apparent decrease in the wound 
contraction area when compared with control group and 250 µg/ml ScLL lectin and at 
day 10, we noticed a complete healing in  the group treated with 500 µg/ml ScLL. (Figure 
2A)  
Wound reduction results of control group and treated groups with ScLL in 250 
and 500 µg/ml in 15 days were demonstrated in Figure2B. Groups treated with 500  µg/ml 
showed significant difference (p<0.05) in the wound reduction area when compared to 
the control group (untreated group) and treated group with 250 µg/ml during the first 
eleven days treatment. However, the group treated with 250 µg/ml demonstrated at no 
time showed significant difference in the wound reduction area when compared to the 
control group. Then, due the animals treated with the highest concentration of ScLL 
demonstrated a better performance in wound reduction, the following experiments was 
performed only with the 500 µg/ml ScLL lectin.  
 
 
3.3. Histological analysis 
For the histological evaluation of the injured tissue, samples of control group and treated 
group with ScLL lectin were collected from each group on 5, 10 and 15 days after 
treatment. Five histological parameters were defined for analysis in HE staining, being 
scored according to their intensity and transformed into quantitative variables, as showed 
in table 1. 
 
3.3.1 Re-epithelization 
In the first five days of treatment, the ScLL treated group demonstrated a more 
advanced reepithelization stage compared to the control group but in discreet intensity. 
At 10 days after surgical wound, the ScLL treated animals showed a intense 
reepithelialization while the control group demonstrated moderate reepithelialization. On 
day 7, both groups showed a level of intense reepithelialization (figure 3A). 
 
3.3.2 Granulation Tissue 
  
 
Concerning the presence of granulation tissue, in the first five days, the ScLL 
treated group showed a intense presence of granulation tissue while control group 
demonstrated a moderated presence. At 10 days of treatment, presence in both groups 
there were a reduced to discrete intensity. Finally, on day 15 after treatment, there was no 
visible granulation tissue for both groups (Figure 3B). 
 
3.3.3. Inflammatory Infiltrate 
The inflammatory infiltrate analyzes on the fifth day demonstrated in the both 
groups a moderate intensity. When evaluated at day 10, there was a decrease of the 
inflammatory infiltrate for both groups, leading to the discrete intensity. On 15 days of 
treatment, control group still demonstrated minimum intensity, while ScLL treated group  
didi not show the presence of inflammatory infiltrate (Figure 3C). 
 
3.3.4 Types of Inflammatory Cells 
Inflammatory cells types were verified and showed in Figure 3D. In the first 5 
days, the ScLL treated group and control group were considered with discrete intensity. 
At 10 days, ScLL treated group changes to intense intensity while control group was to 
moderated intensity. Finally, in 15 days, only control group maintained a discrete 
intensity of inflammatory cells. 
 
3.3.5 Vascular Proliferation 
In the early 5 days of treatment, ScLL treated group showed a moderated to intense 
vascular proliferation, while the control group demonstrated a moderated intensity . On 
days 10, both ScLL treated group and control group had values considered discrete. In 15 
days, none of the groups showed presence of vascular proliferation (Figure 3E). 
 
3.4 Histopathological analysis of the lesions 
 
Histolopathogical analysis were based on histologicals views of scars from treated 
group and control group with a comparation of representative animals for each group after 
5, 10 and 15 days of treatment, as shown in figures 4, 5 and 6. 
With 5 days of treatment it was observed in the control group a very evident and 
thick crust and the granulation tissue poorly formed. In the treated group, a more 
  
 
advanced healing process was observed with lower crust thickness, early re-epithelization 
and well-formed granulation tissue, as shown in figure 4. 
 In 10 days of treatment, the control group still presents a thick crust, but with 
formation of an exuberant granulation tissue in the connective tissue and initiation of re-
epithelialization. In the treated group, an accelerated healing process is observed, with 
complete closure of the wound and formation of epidermal attachments, as shown in 
figure 5. 
Finally, with 15 days of treatment, in the control group, it is possible to note a 
small crust with discrete tissue of underlying granulation, but with formation of epidermal 
attachments. In the treated group was observed a complete skin healing with fully 
epidermis regeneration and restoration of the connective tissue, as shown in figure 6. 
 
3.5 Quantification of collagen 
 
Effect of the ScLL lectin on density and differentiation of collagen was verified 
and shown in Figure 7. The individual analyzes for the presence of total collagen showed 
a gradual increase of collagen fibers in control group. However, ScLL treated group 
demonstrated a decrease of collagen fibers on 15 th day (figure 7A). The presence of type 
1 collagen for the control group also showed a gradual increase during the analyzed days 
of treatment, while in the ScLL treated group there was similar values of type 1 collagen 
on day 5 and on day 10, demonstrated a decrease in day 15 (figure 7B). Concerning about 
the type 3 collagen, the ScLL treated group showed a more marked increase of type 3 
collagen when compared to the control group, maintaining a similar value for 5 and 10 
days and a more visible increase in 15 days. Control group had no significant increase 
from day 5 to day 15. Both increases where observed in smaller values than increases of 
total collagen and type 1 collagen, as shown in figure 7C. Representative microscopic 
images of these data are showed in figure 7D.  
 
4. DISCUSSION 
 
Although only a small portion of all plants in the world are being used as medicinal 
agents, their importance should not be disregarded, since almost 65% of the world's 
population has already incorporated this alternative into their primary health modality. 
Admirably, about one third of all traditional herbal medicines are intended for the 
  
 
treatment of skin wounds and in modern medicines, this value is between 1 and 3%. The 
benefits of plant extracts in the healing of cutaneous wounds have been increasingly 
studied and gained a lot of support from several experimental studies. (BUDOVSKY, et 
al., 2015). 
ScLL lectin did not change the viability of these cells, and similar results were 
demonstrated by Souza et al. (2005) using J774.A1 cells incubated with ScLL in 
concentrations ranging from 1 to 200 µg/ml. Recently, lectins purified of members of the 
Euphorbiaceae (Eutirucallin lectin from the Euphorbia tirucalli latex) did not show any 
effect on cell viability (PALHARINI et al., 2017). Cytotoxicity tests with natural products 
are important because they are a potential source for isolating compounds that can be used 
to develop new therapeutic methods. 
The animals treated with the highest concentration of ScLL demonstrated a better 
performance in wound contraction when compared to control group and treated group 
with smaller concentration. The wound contraction is an essential parameter to the 
progress of cutaneous wound healing because it decreases the wound size, repairs the 
functional barrier and facilitates reepithelization (CHATTOPADHYAY et al., 2002). It 
is known that the skin fragment, when withdrawn, induces a formation of a solution 
consisting of fibrin, clot and inflammatory exudate, resulting in the formation of the 
leukocyte fibrous crust (SIMÕES et al., 1986; MARCHINI, 1994), which indicates the 
beginning of the wound healing process. In addition, the wound healing effect of O. ficus-
indica flower was evidenced by the early formation (between 3 and 5 of post-wounding) 
of scabs (provisional matrix), which protects against irritations and infections, resulting 
in faster healing (AMMAR et al., 2015). Based on these facts, a faster wound contraction 
in group treated with 500 µg/ml when compared with 250/ml ScLL and control groups, 
may be related to the formation of the crust in the early stage. Similar results have been 
demonstrated by other herbal extracts. For instance, the methanolic extract showed faster 
healing with earlier wound contraction when compared with the control group 
(SHIVHARE et al., 2010). 
In the five parameters evaluated on histological analysis, treated group manage to 
get an intense level of re- epithelization sooner than control group, a more intense 
formation of granulation tissue in the beginning of treatment, and "eliminate" the 
inflammatory infiltrates before 15th day, while in the control group these infiltrates were 
still present. On “types of inflammatory cells”, treated group with 500ul/ml evolved from 
5th to 10th day from presence of polymorphonuclear infiltrates to presence of only 
  
 
mononuclear infiltrates, while the control group remained with polymorphonuclear 
infiltrates throughout the treatment evaluation process, and both groups showed similar 
values for vascular proliferation, with a higher concentration of treated group 500ul/ml 
only in the five first days o treatment. Also, control group showed presence of a thick 
fibrin clot during most part of the treatment, while treated group showed a much less thick 
fibrin clot during the begging of analysis, which disappeared with 10 days of treatment 
Healing is a process involving cellular and biochemical responses of the body to recovery 
the function and structure of the damaged tissue (SANTORO; GAUDINO, 2005; 11 
KAPOOR et al., 2006). The process of wound healing is divided in three phases, with 
limits not very distinct: inflammatory phase with two subphases that are homeostasis and 
inflammation itself, proliferate phase and finally the remodeling phase (SUMITRA; 
MANIKANDAN; SUGUNA, 2005). The first step healing process is the control of 
hemorrhage (hemostasis) (LAURENS; KOOLWIJK; DE MAAT, 2006). Hemostasis 
consists of two main processes: platelet deposition, which results in the formation of a 
thrombus platelet, and the activation of the coagulation cascade that results in the 
conversion of fibrinogen into a network of insoluble fibrin filaments, leading the 
formation of the fibrin clot that minimizes the loss of blood, fluids and also provides a 
provisional extracellular matrix for the beginning of the wound organization 
(SANTORO; GAUDINO, 2005; LAURENS; KOOLWIJK; DE MAAT, 2006; 
DIEGELMANN; EVANS, 2004). It is important to emphasize that the inflammatory 
response itself, starting from the conclusion of hemostasis (MOORE, 1999; 
TSIROGIANNI; MOUTSOPOULOS NM; MOUTSOPOULOS HM., 2006). Also the 
inflammation plays a significant role, for stimulating cell migration, proliferation and also 
recruiting fibroblasts to the proliferative phase (MULISA; ASRES; ENGIDAWORK, 
2015). In addition, according to Zekavat et al. (2016), the group treated with 
Carboxymethyl cellulose (CMC) showed a minor degree of haemorrhage and tissue 
necrosis, which accelerates the healing process of diabetic and nondiabetic wounds. In 
this context, on the 5th day of treatment, areas with hemorrhage were observed only in 
treated group with 250ul/ml which may indicate that hemostasis was still in process and 
the healing process may have been more impaired in this group, when compared to control 
and treated group with 500ul/ml. Some studies have demonstrated that the topical 
treatment of natural plant components may delay or hinder the healing process, as 
observed in the study conducted by Araújo (1998) and Contrera (1985). 
  
 
The proliferative phase is the second stage of healing and it is characterized by the 
formation of granulation tissue, which depends primarily on the fibroblast, for 
synthesizing new components of the extracellular matrix, such as collagen fibers type I 
and III, and depends on the formation of new capillary vessels, since they provide 
nutrients for the proliferation and development of cells (GUO; DIPIETRO, 2010; 
CARVALHO, 2002; SILVA, 2014). This tissue consists of cellular elements, including 
fibroblasts, inflammatory cells, and neovascular and matrix components, such as 
fibronectin and proteases (WERNER; GROSE, 2003). It was observed at 5 days that both 
groups already possessed characteristics of granulation tissue. Similar phenomena were 
observed in the study led by Santos et al. (2006), which it was also found on the 7th day 
in both groups studied, the presence of granulation tissue. Moreover, at 15 days were 
observed a reduction of this granulation tissue in animals treated with lectin and control. 
This result is in agreement with Candido (2001) which reports that the proliferative phase 
lasts for 12 to 14 days and occur cell migration, mostly keratinocytes, promoting re-
epithelialization. 
Previous studies demonstrated that deletion of polymorphonuclear cells (PMN) results in 
acceleration of wound closure of full-thickness dermal wounds. (QIAN et al., 2016), so a 
persistence of inflammatory cells in the proliferative phase may have impaired the 
performance of the control group in the stages of wound healing.   
An important stage of wound healing is the regeneration of the blood system to 
restore nutrient perfusion. If this restoration does not happen, the healing process can be 
disrupted or drastically delayed (SORG, Heiko et al). Based on these facts, a higher 
neovascularization rate found on treated group when compared to the control group may 
have been a contributing factor to a faster wound closure process.Collagen is the most 
abundant protein in the human body and it is of fundamental importance in the 
constitution of the skin (EULÁLIO et al., 2007). In the healing process, the collagen 
synthesized by the fibroblasts, initially to compose the extracellular matrix, is degraded 
more actively and a thicker collagen is deposited and organized parallel to the tension 
lines, that is, the collagen fibers undergo a remodeling that contributes to the tissue 
reconstitution and provides tensile strength (MYLLYHARJU; KIVIRIKKO, 2001; 
ISAAC et al., 2010). Taking these factors into consideration the control group, because 
of the higher concentration of collagen at 14 and 21 days after wounding, may have 
contributed to a faster healing of the lesion when compared with the group treated with 
ScLL, giving in the end of the process a greater resistance to the scar. The present findings 
  
 
are similar to those of Abu-albasal (2001) who studied the effect of several plants on 
wound healing (Trigonella foenumgraecum, Artemisia herba-alba, Anchusa strigosa, 
Nigella sativa and Punica granatum) and observed a correlation between the acceleration 
of the wound healing process and the production of collagen. 
According to TREDGET et al. (1997), in some situations an abnormal scarring of 
the skin may occur, causing several disorders, such as keloids. These constantly extend 
beyond the boundaries of the original wound and hardly regresses over time (BRAN et 
al., 2009). Moreover, the keloids occur in individuals with a familial predisposition and 
its characterized by causing persistent pain, itching and have an unappealing appearance 
(BAYAT et al., 2002; OGAWA et al., 2016). The keloids are characterized by an intense 
function and proliferation of fibroblasts, an exorbitant accumulation of extracellular 
matrix, exaggerated deposition of collagen (SU et al., 2010; SHIN; MINN, 2004), 
absence of equilibrium between synthesis and resorption, causing a continuous increase 
of collagen production by being superior to the amount that is degraded, and fibroblast 
resistance to apoptosis (KREISNER et al., 2005; ISAAC et al., 2011). In agreement with 
this, the group treated with ScLL 500 μg/ml may contribute as a form of treatment or 
prevention in the formation of keloids in the healing process, by minimizing the 
accumulation of collagen, since it presented lower collagen deposition at 15 days of 
treatment. A similar result was demonstrated in a study with Calotropis latex, suggesting 
that it that can be used in the treatment of keloids, because of the ability to inhibit intense 
response of fibroblasts, accumulation of collagen in the matrix and to induce florid 
granulation tissues (ADEROUNMUA et al., 2013). 
 
5. CONCLUSION 
In conclusion, the present investigation describes the healing potencial of topical 
administration of the S. carinatum lectin on surgically induced wounds. The properties of 
the ScLL lectin here reported indicate that it demonstrates hemagglutinating activity, 
without hemolytic and cytotoxic effects. Concerning the macroscopic evaluation, ScLL 
lectin presented better performance in the wound contraction and re-epithelialization 
faster than control group, however ashowed lower deposition of collagen. Despite this, 
the lectin (ScLL 500 μg/ml) could be a potential source of therapeutic agents in the 
prevention and treatment of keloids, due the ability of inhibit exaggerated accumulation 
of collagen in the matrix. 
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Figure 1. Purification of ScLL lectin from S. carynatum and its hemagglutinating, 
hemolytic and cytotoxic activity (A) ScLL purification by galactose affinity 
chromatography. The first peak (a) corresponds to galactose non-binding proteins (void) 
and the second peak (b) is related to galactose binding proteins (GBP) eluted with 400 
mM of galactose. (B) SDS-PAGE from S. carynatum: line 1) crude extract; line 2) non-
binding proteins; line 3) ScLL lectin analyzed under non-reducing conditions revealed 
two proteins of approximately 28 and 30 kDa. (C) ScLL lectin presented 
hemagglutinating activity (25-1.55 µg), (D) Percentage of hemolysis in Balb/c mice 
erythrocytes, indicating that ScLL lectin is not hemolytic; and (E) Percentage of cell 
viability using Human Foreskin Fibroblasts (HFF) and peritoneal murine macrophages 
demonstrated that in different concentrations the ScLL lectinn is not cytotoxic. 
 
Figure 2. Photographic representation of wound contraction on different post wounding 
days of the control group and ScLL lectin treated groups, demonstrated better result in 
500 μg/ml concentration when compared with 250 μg/ml and control. 
 
Figure 3. (A) Graph showing the intensity of reepithelialization, (B) intensity of 
granulation tissue, (C) intensity of Inflammatory Infiltrate, (D) intensity of different 
Types of Inflammatory Cells and (E) intensity of Vascular Proliferation. 
Figure 4. Representative photomicrography of the skin of control group and ScLL treated 
group at 5-day after surgical injury. In the control group, was observed that granulation 
tissue is still poorly developed with the presence of a thick fibrin clot. In the Scll treated 
group, notice a much less thick fibrin clot, the granulation tissue is well developed, and 
the epidermis shows an accelerated reepithelization, but without epidermal appendages 
formation. 
 
Figure 5. Representative photomicrography of the skin of control group and ScLL treated 
group at 10-day after surgical injury. In the control group is still evident the presence of 
a thick fibrin clot; the granulation tissue is already formed in the connective tissue, and 
began the epidermis reepithelization. Comparing the ScLL treated group, notice an 
advanced process of healing with complete re-epithelization of the epidermis. 
  
 
 
Figure 6. Representative photomicrography of the skin of  the control group and ScLL-
treated group at 15-day after surgical injury. In the control group, note permanence of 
fibrin clot and an underlying granulation tissue; the epidermis appendage regeneration is 
already observed in the connective tissue. In the ScLL treated group, see a complete skin 
healing with fully epidermis regeneration and restoration of the connective tissue. 
 
Figure 7. Concentration collagen analyzes after 5, 10 and 15 day of treatment with ScLL 
from S. carinatum. (A) Concentration of total collagen; (B) Concentration of type 1 
collagen.; (C) Concentration of type 3 collagen. Values are expressed in mean ± S.D. 
*P˃0.05 compared with the control group.  (D) Photomicrograph of histological sections 
showing the density of the different types of collagen by polarized microscopy of the 
control group and ScLL treated group after 5, 10 and 15 days of treatment (Sirius Red – 
20X). 
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